Breast Cancer: Targets and Therapy

Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective

ESMO Open

How I Treat Metastatic Triple-Negative Breast Cancer

Nature Reviews Clinical Oncology

Immune-Checkpoint Inhibition for Metastatic Triple-Negative Breast Cancer: Safety First?

Scientific Reports

Addition of Immune Checkpoint Inhibitors to Chemotherapy Versus Chemotherapy Alone in First-Line Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Journal of Oncology Pharmacy Practice

Case Report of Sacituzumab Govitecan-hziy-Induced Neutropenia in a Patient With Metastatic Triple-Negative Breast Cancer and a Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 Poor Metabolizer Genotype

Pharmaceuticals

Immunotherapy Treatment for Triple Negative Breast Cancer

2021 San Antonio Breast Cancer Symposium

Datopotamab Deruxtecan in Advanced/Metastatic HER2- Breast Cancer: Results From the Phase 1 TROPION-Pantumor01 Study

The ASCO Post

KEYNOTE-355 Final Analysis Reveals Survival Benefit With Pembrolizumab in Triple-Negative Breast Cancer

Asia-Pacific Journal of Clinical Oncology

Metastatic Triple Negative Breast Cancer: Optimizing Treatment Options, New and Emerging Targeted Therapies

New England Journal of Medicine

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer